Skip to main content
SpringerLink
Log in

Survey of adverse events following ChAdOx1 COVID-19 vaccination in Ethiopia

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Muluneh AG, et al. More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia Infection and Drug Resistance : 13 May 2022. Available from: URL: https://doi.org/10.2147/IDR.S360605

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Survey of adverse events following ChAdOx1 COVID-19 vaccination in Ethiopia. Reactions Weekly 1907, 12 (2022). https://doi.org/10.1007/s40278-022-15271-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15271-0

Search

Navigation